Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis.

S. Vosslamber, H.G. Raterman, T. van der Pouw Kraan, M.W.J. Schreurs, B.M. von Blomberg, M.T. Nurmohamed, W.F. Lems, B.A. Dijkmans, A.E. Voskuyl, C.L. Verweij

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1153-1159
JournalAnnals of the Rheumatic Diseases
Volume70
Issue number6
DOIs
Publication statusPublished - 2011

Cite this